Cosnderm Dermaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 94.19%
- Profit Growth 55.37%
- Ebitda -58.95%
- Net Worth 131.52%
- Total Assets 61.28%
About Cosnderm Dermaceuticals
Cosnderm Dermaceuticals Private Limited (CDPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 July 2020 (Four years and seven months 3 days old ). Its registered office is in Delhi, India.
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Tapesh Sharma and Richa Sharma serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100DL2020PTC366656
- Company No.
366656
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jul 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Cosnderm Dermaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tapesh Sharma  | Director | 22-Jul-2020 | Current |
| Richa Sharma | Director | 22-Jul-2020 | Current |
Financial Performance of Cosnderm Dermaceuticals.
Cosnderm Dermaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 94.19% increase. The company also saw a substantial improvement in profitability, with a 55.37% increase in profit. The company's net worth Soared by an impressive increase of 131.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cosnderm Dermaceuticals?
Unlock access to Cosnderm Dermaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Maxdermcare Skin And Laser Private LimitedTapesh Sharma and Richa Sharma are mutual person
Red Kadamba Innovations Private LimitedRicha Sharma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cosnderm Dermaceuticals?
Cosnderm Dermaceuticals has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cosnderm Dermaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cosnderm Dermaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
